ArticleNature chemical biology2018

Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer.

Hayley J Donnella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.